CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C31604 | BRD-K92073408 | BRD-K92073408 | -- | -- | norethisterone | Details |
C31605 | BRD-K92079609 | BRD-K92079609 | -- | -- | -- | Details |
C31606 | BRD-K92079660 | BRD-K92079660 | -- | -- | -- | Details |
C31607 | BRD-K92084213 | MW-SHH-61 | -- | -- | -- | Details |
C31608 | BRD-K92093830 | doxorubicin | TOP2A | Topoisomerase inhibitor | -- | Details |
C31609 | BRD-K92096002 | BRD-K92096002 | -- | -- | -- | Details |
C31610 | BRD-K92107474 | BRD-K92107474 | -- | -- | -- | Details |
C31611 | BRD-K92123432 | ginkgetin | -- | -- | -- | Details |
C31612 | BRD-K92124212 | BRD-K92124212 | -- | -- | -- | Details |
C31613 | BRD-K92125320 | BRD-K92125320 | -- | -- | -- | Details |
C31614 | BRD-K92129045 | caroxazone | -- | -- | -- | Details |
C31615 | BRD-K92129795 | BRD-K92129795 | -- | -- | -- | Details |
C31616 | BRD-K92132228 | BRD-K92132228 | -- | -- | -- | Details |
C31617 | BRD-K92134254 | BRD-K92134254 | -- | -- | -- | Details |
C31618 | BRD-K92134560 | BRD-K92134560 | -- | -- | -- | Details |
C31619 | BRD-K92135888 | BRD-K92135888 | -- | -- | -- | Details |
C31620 | BRD-K92135892 | BRD-K92135892 | -- | -- | -- | Details |
C31621 | BRD-K92137277 | BRD-K92137277 | -- | -- | -- | Details |
C31622 | BRD-K92138166 | mammea-a | -- | -- | -- | Details |
C31623 | BRD-K92140823 | BRD-K92140823 | -- | -- | -- | Details |
C31624 | BRD-K92144896 | BRD-K92144896 | -- | -- | -- | Details |
C31625 | BRD-K92158425 | BRD-K92158425 | -- | -- | -- | Details |
C31626 | BRD-K92159000 | BRD-K92159000 | -- | -- | -- | Details |
C31627 | BRD-K92167235 | sodium-phenylacetate | -- | -- | -- | Details |
C31628 | BRD-K92167240 | BRD-K92167240 | -- | -- | -- | Details |
C31629 | BRD-K92169341 | URB-597 | -- | -- | -- | Details |
C31630 | BRD-K92172862 | BRD-K92172862 | -- | -- | -- | Details |
C31631 | BRD-K92176613 | BRD-K92176613 | -- | -- | Heptanoic acid (4-hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl)-amide | Details |
C31632 | BRD-K92180676 | BRD-K92180676 | -- | -- | -- | Details |
C31633 | BRD-K92186740 | BRD-K92186740 | -- | -- | -- | Details |
C31634 | BRD-K92191596 | BRD-K92191596 | -- | -- | -- | Details |
C31635 | BRD-K92191804 | BRD-K92191804 | -- | -- | -- | Details |
C31636 | BRD-K92193792 | nizatidine | HRH2 | Histamine receptor antagonist | -- | Details |
C31637 | BRD-K92195351 | BRD-K92195351 | -- | -- | -- | Details |
C31638 | BRD-K92202681 | BRD-K92202681 | -- | -- | -- | Details |
C31639 | BRD-K92202821 | BRD-K92202821 | -- | -- | -- | Details |
C31640 | BRD-K92205342 | BRD-K92205342 | -- | -- | -- | Details |
C31641 | BRD-K92208021 | BRD-K92208021 | -- | -- | -- | Details |
C31642 | BRD-K92209998 | BRD-K92209998 | -- | -- | -- | Details |
C31643 | BRD-K92210276 | BRD-K92210276 | -- | -- | -- | Details |
C31644 | BRD-K92210988 | BRD-K92210988 | -- | -- | -- | Details |
C31645 | BRD-K92212152 | BRD-K92212152 | -- | -- | -- | Details |
C31646 | BRD-K92213669 | lomitapide | MTTP | Microsomal trigylceride transfer protein inhibitor | -- | Details |
C31647 | BRD-K92219497 | BRD-K92219497 | -- | -- | -- | Details |
C31648 | BRD-K92232855 | BRD-K92232855 | -- | -- | -- | Details |
C31649 | BRD-K92239253 | BRD-K92239253 | -- | -- | -- | Details |
C31650 | BRD-K92241597 | tosedostat | ANPEP; LAP3; NPEPPS | Peptidase inhibitor | -- | Details |
C31651 | BRD-K92241728 | BRD-K92241728 | -- | -- | -- | Details |
C31652 | BRD-K92242945 | BRD-K92242945 | -- | -- | -- | Details |
C31653 | BRD-K92246187 | BRD-K92246187 | -- | -- | -- | Details |
C31654 | BRD-K92266998 | BRD-K92266998 | -- | -- | -- | Details |
C31655 | BRD-K92269212 | BRD-K92269212 | -- | -- | -- | Details |
C31656 | BRD-K92269225 | KU-C103881 | -- | -- | -- | Details |
C31657 | BRD-K92276921 | p-rosaniline.hcl | -- | -- | -- | Details |
C31658 | BRD-K92277566 | BRD-K92277566 | -- | -- | -- | Details |
C31659 | BRD-K92291448 | BRD-K92291448 | -- | -- | -- | Details |
C31660 | BRD-K92300676 | BRD-K92300676 | -- | -- | -- | Details |
C31661 | BRD-K92301463 | BRD-K92301463 | -- | -- | 16,16-dimethylprostaglandin-e2 | Details |
C31662 | BRD-K92302554 | BRD-K92302554 | -- | -- | -- | Details |
C31663 | BRD-K92303087 | oglemilast | -- | -- | -- | Details |
C31664 | BRD-K92310201 | mometasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C31665 | BRD-K92311828 | BRD-K92311828 | -- | -- | -- | Details |
C31666 | BRD-K92312193 | BRD-K92312193 | -- | -- | -- | Details |
C31667 | BRD-K92313046 | BRD-K92313046 | -- | -- | -- | Details |
C31668 | BRD-K92317137 | BRD-K92317137 | -- | -- | -- | Details |
C31669 | BRD-K92326486 | BRD-K92326486 | -- | -- | -- | Details |
C31670 | BRD-K92327934 | BRD-K92327934 | -- | -- | -- | Details |
C31671 | BRD-K92331543 | BRD-K92331543 | -- | -- | -- | Details |
C31672 | BRD-K92333822 | BRD-K92333822 | -- | -- | -- | Details |
C31673 | BRD-K92334440 | BRD-K92334440 | -- | -- | -- | Details |
C31674 | BRD-K92343999 | KU-C104253 | -- | -- | -- | Details |
C31675 | BRD-K92344227 | BRD-K92344227 | -- | -- | -- | Details |
C31676 | BRD-K92347680 | BRD-K92347680 | -- | -- | -- | Details |
C31677 | BRD-K92349794 | BRD-K92349794 | -- | -- | -- | Details |
C31678 | BRD-K92356128 | BRD-K92356128 | -- | -- | -- | Details |
C31679 | BRD-K92356505 | BRD-K92356505 | -- | -- | -- | Details |
C31680 | BRD-K92358687 | BRD-K92358687 | -- | -- | -- | Details |
C31681 | BRD-K92359570 | BRD-K92359570 | -- | -- | -- | Details |
C31682 | BRD-K92361663 | BRD-K92361663 | -- | -- | -- | Details |
C31683 | BRD-K92364610 | BRD-K92364610 | -- | -- | -- | Details |
C31684 | BRD-K92365616 | BRD-K92365616 | -- | -- | -- | Details |
C31685 | BRD-K92367471 | BRD-K92367471 | -- | -- | -- | Details |
C31686 | BRD-K92370559 | BRD-K92370559 | -- | -- | -- | Details |
C31687 | BRD-K92372623 | BRD-K92372623 | -- | -- | -- | Details |
C31688 | BRD-K92372829 | BRD-K92372829 | -- | -- | -- | Details |
C31689 | BRD-K92373832 | BRD-K92373832 | -- | -- | -- | Details |
C31690 | BRD-K92374432 | BRD-K92374432 | -- | -- | -- | Details |
C31691 | BRD-K92378241 | BRD-K92378241 | -- | -- | -- | Details |
C31692 | BRD-K92379545 | BRD-K92379545 | -- | -- | -- | Details |
C31693 | BRD-K92398088 | BRD-K92398088 | -- | -- | -- | Details |
C31694 | BRD-K92399035 | BRD-K92399035 | -- | -- | -- | Details |
C31695 | BRD-K92399508 | BRD-K92399508 | -- | -- | -- | Details |
C31696 | BRD-K92404805 | BRD-K92404805 | -- | -- | L-quisqualic-acid | Details |
C31697 | BRD-K92412252 | SA-1920722 | -- | -- | -- | Details |
C31698 | BRD-K92413528 | thiazolidinecarboxylic-acid | -- | -- | -- | Details |
C31699 | BRD-K92419424 | BRD-K92419424 | -- | -- | -- | Details |
C31700 | BRD-K92428153 | mycophenolate-mofetil | IMPDH1; IMPDH2 | IMPDH inhibitor; IMPase inhibitor; Immunosuppressant; Dehydrogenase inhibitor; Hydroxycarboxylic acid receptor agonist | -- | Details |
C31701 | BRD-K92428232 | GSK-461364 | PLK1 | PLK inhibitor | -- | Details |
C31702 | BRD-K92431275 | BRD-K92431275 | -- | -- | -- | Details |
C31703 | BRD-K92431661 | BRD-K92431661 | -- | -- | -- | Details |